No insider purchase over the last 90 days. The latest, by 杜立威, was filed 08 Aug 2023.
Amoy Diagnostics Co., Ltd.: what insiders have been doing
Amoy Diagnostics Co., Ltd. belongs to the Health Care sector. Filings by its managers are published through SSE / SZSE (CSRC). The past year has been quiet: not a single insider filing for Amoy Diagnostics Co., Ltd. The previous disclosure was published on 8 August 2023.
Looking back to 2021, when coverage begins, insiders filed 1 purchase and 2 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Vetoquinol SA. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Since the insiders bought
- -24.7%Entry CN¥25.09 · Close at T+365 CN¥18.89
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
About Amoy Diagnostics Co., Ltd.
艾德生物 is a company specializing in the health and pharmaceutical sector, focused on developing biopharmaceutical solutions. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
